Friday, May 1, 2026

THE UN HAMMER Drops: Kim Jong Un Suddenly Pivots to ‘Child Care’ After 21 Years of Global Shame

North Korea claims its child policies surpass those of developed nations, countering UN human rights resolutions and emphasizing Kim Jong Un's leadership.

August Export Surge: South Korea’s $57.9 Billion Record and What It Means

South Korea achieved its highest-ever monthly export total in August, with $56 b, driven by strong IT product sales and record EU exports.

Tag: SK Biopharmaceuticals

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

SK Biopharmaceuticals Selects Two CNS Startups Through Open Innovation… Advances Expected in Parkinson’s and Alzheimer’s Treatment

SK Biopharmaceuticals partners with Seoul Bio Hub to support two CNS startups, Novorex and Threebrooks, in innovative drug development.

Exploring Cenobamate: How SK Biopharmaceuticals’ New Oral Suspension Benefits Adult Epilepsy Patients

SK Biopharmaceuticals submits NDA for Cenobamate oral suspension, enhancing treatment options for epilepsy patients with swallowing difficulties.

SK Biofarm, FDA Approved Radioactive Method: Will it be a Revolutionary Cancer Cure with SLK 33501?

SK Biopharmaceuticals gains FDA approval for Phase 1 trials of radiopharmaceuticals SKL35501 and SKL35502, advancing cancer treatment.

Top News

- Our Sponsors Ad -

Follow us